Skip to main content

Table 5 Association between polymorphisms and COPD risk stratified by smoking

From: LINC01414/LINC00824 genetic polymorphisms in association with the susceptibility of chronic obstructive pulmonary disease

SNP ID

Model

Genotype

Case

Control

OR (95%CI)

p

Case

Control

OR (95%CI)

p

Case

Control

OR (95%CI)

p

Smoking

  

Current

Former

Never

LINC00824

rs7815944

Allele

A

123

47

1

 

97

21

1

 

239

178

1

 

G

43

21

0.78 (0.42–1.45)

0.438

31

15

0.45 (0.21–0.97)

0.040*

93

58

1.19 (0.82–1.75)

0.361

Genotype

AA

43

16

1

 

36

8

1

 

87

65

1

 

AG

37

15

0.93 (0.40–2.15)

0.867

25

5

1.08 (0.30–3.94)

0.906

65

48

0.99 (0.6–1.62)

0.966

GG

3

3

0.36 (0.06–2.02)

0.246

3

5

0.17 (0.03–0.96)

0.044*

14

5

1.96 (0.66–5.76)

0.223

Dominant

AA

43

16

1

 

36

8

1

 

87

65

1

 

AG-GG

40

18

0.83 (0.37–1.85)

0.647

28

10

0.68 (0.21–2.14)

0.506

79

53

1.08 (0.67–1.74)

0.751

Recessive

AA-AG

80

31

1

 

61

13

1

 

152

113

1

 

GG

3

3

0.37 (0.07–2.01)

0.250

3

5

0.16 (0.03–0.84)

0.031*

14

5

1.97 (0.68–5.66)

0.211

Log-additive

  

0.76 (0.39–1.48)

0.413

  

0.52 (0.22–1.20)

0.124

  

1.17 (0.79–1.72)

0.443

  1. p values were calculated by logistic regression analysis adjusted by age and gender
  2. Bold indicate that p < 0.05 means the data is statistically significant
  3. COPD chronic obstructive pulmonary disease, SNP single nucleotide polymorphism, OR odds ratio, 95% CI 95% confidence interval